Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?

Por Wysocki, Jan, Batlle, Daniel
Publicado em 2013

Urinary Angiotensinogen: A Promising Biomarker of AKI Progression in Acute Decompensated Heart Failure: What Does It Mean?

Por Wysocki, Jan, Batlle, Daniel
Publicado no Clin J Am Soc Nephrol (2016)

Vascular ACE2: Lord of the Ring?

Por Batlle, Daniel, Wysocki, Jan, Khan, Mirza S.
Publicado em 2010

ANGIOTENSINS AND THE HEART: IS ANG 1-7 CARDIOPROTECTIVE?

Por Wysocki, Jan, Wilsbacher, Lisa, Batlle, Daniel
Publicado no Hypertension (2015)

Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis

Por Wysocki, Jan, Ye, Minghao, Batlle, Daniel
Publicado no Am J Hypertens (2015)

ACE2 and Diabetes: ACE of ACEs?

Por Batlle, Daniel, Jose Soler, Maria, Ye, Minghao
Publicado em 2010

New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy

Por Soler, María José, Riera, Marta, Batlle, Daniel
Publicado em 2012

Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies

Por Haque, Syed K., Ariceta, Gema, Batlle, Daniel
Publicado em 2012

ACE2 alterations in kidney disease

Por Soler, María José, Wysocki, Jan, Batlle, Daniel
Publicado em 2013

The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?

Por Batlle, Daniel, Boobés, Khaled, Manjee, Kiran G.
Publicado no EBioMedicine (2015)

The GTP-binding Protein RhoA Mediates Na,K-ATPase Exocytosis in Alveolar Epithelial Cells

Por Lecuona, Emilia, Ridge, Karen, Pesce, Liuska, Batlle, Daniel, Sznajder, Jacob I.
Publicado em 2003

Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease

Por Wang, Xiaofang, Harris, Peter C., Somlo, Stefan, Batlle, Daniel, Torres, Vicente E.
Publicado em 2009

Endothelin Receptor-A Antagonist Attenuates Retinal Vascular and Neuroretinal Pathology in Diabetic Mice

Por Chou, Jonathan C., Rollins, Stuart D., Ye, Minghao, Batlle, Daniel, Fawzi, Amani A.
Publicado no Invest Ophthalmol Vis Sci (2014)

ACE2-Independent Action Of Presumed ACE2 Activators: Studies In Vivo, Ex Vivo and In Vitro

Por Haber, Philipp K., Ye, Minghao, Wysocki, Jan, Maier, Christoph, Haque, Syed K., Batlle, Daniel
Publicado em 2014

Evaluation of Renal Hypoxia in Diabetic Mice by BOLD MRI

Por Prasad, Pottumarthi, Li, Lu-Ping, Halter, Sarah, Cabray, JoAnn, Ye, Minghao, Batlle, Daniel
Publicado no Invest Radiol (2010)

A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13

Por Liu, Pan, Wysocki, Jan, Serfozo, Peter, Ye, Minghao, Souma, Tomokazu, Batlle, Daniel, Jin, Jing
Publicado no Sci Rep (2017)

Regulation of urinary ACE2 in diabetic mice

Por Wysocki, Jan, Garcia-Halpin, Laura, Ye, Minghao, Maier, Christoph, Sowers, Kurt, Burns, Kevin D., Batlle, Daniel
Publicado em 2013

Predominance of AT(1) Blockade Over Mas–Mediated Angiotensin-(1–7) Mechanisms in the Regulation of Blood Pressure and Renin–Angiotensin System in mRen2.Lewis Rats

Por Varagic, Jasmina, Ahmad, Sarfaraz, VonCannon, Jessica L., Moniwa, Norihito, Brosnihan, K. Bridget, Wysocki, Jan, Batlle, Daniel, Ferrario, Carlos M.
Publicado em 2013

Murine Recombinant ACE2: Effect on Angiotensin II Dependent Hypertension and Distinctive ACE2 Inhibitor Characteristics on rodent and human ACE2

Por Ye, Minghao, Wysocki, Jan, Gonzales-Pacheco, Francisco R., Salem, Mahmoud, Evora, Karla, Garcia-Halpin, Laura, Poglitsch, Marko, Schuster, Manfred, Batlle, Daniel
Publicado em 2012

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

Por Nadarajah, Renisha, Milagres, Rosangela, Dilauro, Marc, Gutsol, Alex, Xiao, Fengxia, Zimpelmann, Joseph, Kennedy, Chris, Wysocki, Jan, Batlle, Daniel, Burns, Kevin D
Publicado em 2012